The Kislinger Laboratory is located at the Princess Margaret Cancer Research Tower of the Princess Margaret Cancer Centre, the largest oncology treatment and research facility in Canada. The major goal of our lab is to apply proteomics technologies to cancer and cardiovascular research. Our research interests include technology development, using the latest generation of mass spectrometry instrumentation, basic cell biology and translational cancer research.
Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
Neuro Oncol. 2017 Jul 28;:
Proteomics. 2017 Sep 18;:
Nat Commun. 2017 Aug 24;8(1):331
A novel community driven software for functional enrichment analysis of extracellular vesicles data.
J Extracell Vesicles. 2017;6(1):1321455
Genome Med. 2017 Jul 18;9(1):62
Quantitative proteomics of intestinal mucosa from male mice lacking intestinal epithelial insulin receptors.
Endocrinology. 2017 Jun 07;:
HLA-DP(84Gly) constitutively presents endogenous peptides generated by the class I antigen processing pathway.
Nat Commun. 2017 May 10;8:15244
Curr Protoc Protein Sci. 2017 Feb 02;87:24.9.1-24.9.12
Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Int J Cancer. 2016 Oct 17;:
Senior Scientist, Princess Margaret Cancer Centre